You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 60 No. 12, December 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (46)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Neurogenetics
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Spinocerebellar Ataxia Type 14 Caused by a Mutation in Protein Kinase C {gamma}

Ichiro Yabe, MD, PhD; Hidenao Sasaki, MD, PhD; Dong-Hui Chen, MD, PhD; Wendy H. Raskind, MD, PhD; Thomas D. Bird, MD; Isao Yamashita, MD, PhD; Shoji Tsuji, MD, PhD; Seiji Kikuchi, MD, PhD; Kunio Tashiro, MD, PhD

Arch Neurol. 2003;60:1749-1751.

Background  We previously discovered spinocerebellar ataxia type 14 (SCA14) in a single Japanese family with an autosomal dominant neurodegenerative disorder characterized by cerebellar ataxia and intermittent axial myoclonus. The latter manifestation is selectively observed in patients with early onset. We mapped the locus to chromosome 19q13.4-qter, but the etiologic gene was not known. Recently, a mutation in the protein kinase C {gamma} gene (PRKCG) was identified in a US family of English and Dutch ancestry with autosomal dominant SCA whose disease mapped to a region overlapping that of the SCA14 locus. Different PRKCG mutations were found in another family with SCA and in a sporadic case from the United States. Axial myoclonus was not observed in any of these US families.

Objectives  To determine whether a mutation in the PRKCG gene is responsible for SCA14 and to investigate the prevalence of PRKCG mutations in Japanese patients with autosomal dominant SCA.

Patients and Methods  Direct nucleotide sequencing analysis of the 18 coding exons of the PRKCG gene was performed in the 19 members of the original Japanese family with SCA14 and in 24 Japanese probands with SCA. After identifying a PRKCG mutation, DNA samples from 72 patients with multiple system atrophy and 50 healthy individuals were examined for the mutation as controls.

Results  Sequence analysis revealed a novel missense mutation, Gln127Arg, in all affected members of the family with SCA14. This mutation was not found in 122 control individuals. No mutations in the PRKCG gene were detected in the group of 24 probands with SCA of unknown type.

Conclusions  These findings document that SCA14 is caused by mutations in the PRKCG gene. The observation that all 4 PRKCG mutations identified in patients with SCA to date are located in exon 4 suggests a critical role for this region of the gene in cerebellar function. Mutations in the same region of the gene can result in myoclonus in some families but not in others.


From the Department of Neurology, Hokkaido University Graduate School of Medicine, Sapporo, Japan (Drs Yabe, Sasaki, Kikuchi, and Tashiro); Departments of Neurology (Drs Chen and Bird) and Medicine (Dr Raskind), University of Washington, Seattle; and Departments of Neurology, University of California, San Francisco, (Dr Yamashita) and Tokyo University Graduate School of Medicine, Tokyo, Japan (Dr Tsuji).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Fluorescence resonance energy transfer imaging of PKC signalling in living cells using genetically encoded fluorescent probes
Goedhart and Gadella
J R Soc Interface 2009;6:S27-S34.
ABSTRACT | FULL TEXT  

PKC{gamma} mutations in spinocerebellar ataxia type 14 affect C1 domain accessibility and kinase activity leading to aberrant MAPK signaling
Verbeek et al.
J. Cell Sci. 2008;121:2339-2349.
ABSTRACT | FULL TEXT  

The contactin 4 gene locus at 3p26 is a candidate gene of SCA16.
Miura et al.
Neurology 2006;67:1236-1241.
ABSTRACT | FULL TEXT  

Molecular pathogenesis of spinocerebellar ataxias
Duenas et al.
Brain 2006;129:1357-1370.
ABSTRACT | FULL TEXT  

Spinocerebellar ataxia type 14: study of a family with an exon 5 mutation in the PRKCG gene
Fahey et al.
J. Neurol. Neurosurg. Psychiatry 2005;76:1720-1722.
ABSTRACT | FULL TEXT  

Mutant Protein Kinase C{gamma} Found in Spinocerebellar Ataxia Type 14 Is Susceptible to Aggregation and Causes Cell Death
Seki et al.
J. Biol. Chem. 2005;280:29096-29106.
ABSTRACT | FULL TEXT  

The clinical and genetic spectrum of spinocerebellar ataxia 14
Chen et al.
Neurology 2005;64:1258-1260.
ABSTRACT | FULL TEXT  

Protein kinase C gamma mutations in spinocerebellar ataxia 14 increase kinase activity and alter membrane targeting
Verbeek et al.
Brain 2005;128:436-442.
ABSTRACT | FULL TEXT  

Mapping of the SCA23 locus involved in autosomal dominant cerebellar ataxia to chromosome region 20p13-12.3
Verbeek et al.
Brain 2004;127:2551-2557.
ABSTRACT | FULL TEXT  

Mutation in the Catalytic Domain of Protein Kinase C {gamma} and Extension of the Phenotype Associated With Spinocerebellar Ataxia Type 14
Stevanin et al.
Arch Neurol 2004;61:1242-1248.
ABSTRACT | FULL TEXT  

Dominantly inherited ataxia and dysphonia with dentate calcification: spinocerebellar ataxia type 20
Knight et al.
Brain 2004;127:1172-1181.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.